small molecule drugs

Small Biotech, Neuropore Therapies, Tackles Big Disease Area
Small Biotech, Neuropore Therapies, Tackles Big Disease Area
Xtalks
Neuropore Therapies
small molecule drugs
neurodegenerative disease
Flag link:
Vividion Raises $82M to Advance Small Molecule Drugs to the Clinic
Vividion Raises $82M to Advance Small Molecule Drugs to the Clinic
Xconomy
Vividion Therapeutics
small molecule drugs
Scripps Research Institute
Flag link:
Janssen, Scripps discover small molecule for flu
Janssen, Scripps discover small molecule for flu
BioCentury
JNJ
Janssen
Scripps Research Institute
Flu
influenza
small molecule drugs
Flag link:
Renamed Axovant could see big gains in 2019: analysts
Renamed Axovant could see big gains in 2019: analysts
Fierce Biotech
Axovant Sciences
Axovant Gene Therapies
small molecule drugs
Flag link:
Genentech Licenses Non-CF Compound From Proteostasis in $100 Million-Plus Deal
Genentech Licenses Non-CF Compound From Proteostasis in $100 Million-Plus Deal
BioSpace
Genentech
Proteostasis Therapeutics
small molecule drugs
Flag link:
Axovant dumps nelotanserin in retreat from small molecule R&D
Axovant dumps nelotanserin in retreat from small molecule R&D
Fierce Biotech
Axovant
nelotanserin
dementia with Lewy bodies
clinical trials
R&D
small molecule drugs
Flag link:
Evotec and Ferring Team Up to Work on Women's Health Issues
Evotec and Ferring Team Up to Work on Women's Health Issues
CP Wire
Evotec
Ferring
small molecule drugs
Women's Health
Fertility
Flag link:
Neurocrine, Jnana team up to discover CNS drugs
Neurocrine, Jnana team up to discover CNS drugs
Fierce Biotech
Neurocrine Biosciences
Jnana Therapeutics
small molecule drugs
CNS
drug discovery
Flag link:
Novo Nordisk adds to diabetes pipeline with Evotec deal
Novo Nordisk adds to diabetes pipeline with Evotec deal
Fierce Biotech
Novo Nordisk
Evotec
drug development
small molecule drugs
obesity
diabetes
Flag link:
Effector Raises $38.6M to Advance New Class of Anti-Cancer Drugs
Effector Raises $38.6M to Advance New Class of Anti-Cancer Drugs
Xconomy
Effector
small molecule drugs
venture capital
Flag link:
Sanofi to bulldoze small molecule plant it never used
Sanofi to bulldoze small molecule plant it never used
Fierce Pharma
Sanofi
small molecule drugs
drug manufacturing
Flag link:
Sanofi inks €250M bispecific small molecule diabetes deal
Sanofi inks €250M bispecific small molecule diabetes deal
Fierce Biotech
Sanofi
small molecule drugs
diabetes
Exscientia
Flag link:
Pfizer Completes Acquisition of Small Molecule Anti-Infective Business From AstraZeneca
Pfizer Completes Acquisition of Small Molecule Anti-Infective Business From AstraZeneca
Yahoo
Pfizer
M&A
AstraZeneca
small molecule drugs
anti-infectives
Flag link:
Cambrex to Acquire PharmaCore Inc., to Expand Clinical Stage API Capabilities
Cambrex to Acquire PharmaCore Inc., to Expand Clinical Stage API Capabilities
Cafepharma/Globe Newswire
Cambrex
PharmaCore
M&A
APIs
small molecule drugs
drug manufacturing
Flag link:
Allied Minds, Bristol-Myers Squibb to progress first drug to preclinical trials
Allied Minds, Bristol-Myers Squibb to progress first drug to preclinical trials
Bizjournals.com
Allied Minds
Bristol-Myers Squibb
small molecule drugs
Flag link:
One Biotech CEO's Plan To Slash The Cost Of Cancer Immunotherapy
One Biotech CEO's Plan To Slash The Cost Of Cancer Immunotherapy
Forbes
Curis
Aurigene
immuno-oncology
small molecule drugs
Flag link:
Sanofi, UCB enter small-molecule drug development deal for immune-mediated diseases
Sanofi, UCB enter small-molecule drug development deal for immune-mediated diseases
First Word Pharma
Sanofi
UCB Pharmaceuticals
small molecule drugs
drug development
Flag link:
Cellceutix to Commence Clinical Trials for Its Novel Anti-Cancer Drug Kevetrin
Cellceutix to Commence Clinical Trials for Its Novel Anti-Cancer Drug Kevetrin
Yahoo
Cellceutix
Kevetrin
small molecule drugs
Flag link:
Expecting Catalyst Action For Astex Pharmaceuticals
Expecting Catalyst Action For Astex Pharmaceuticals
Seeking Alpha
Astex
Dacogen
small molecule drugs
Flag link:
Takeda To Buy Small-Molecule Drug Maker For Up To $310 Million
Takeda To Buy Small-Molecule Drug Maker For Up To $310 Million
WSJ Online
Takeda
small molecule drugs
M&A
Intellikine
Flag link:

Pages